Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Harris

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|April 8, 1998
A bispecific monoclonal antibody directed against both the membrane-bound complement regulator CD55 and the renal tumor-associated antigen G250 enhances C3 deposition and tumor cell lysis by complementV T Blok, M R Daha, O Tijsma, et al.
Neuroreport|May 6, 1997
Processing of presenilin 1 in brains of patients with Alzheimer's disease and controlsL Hendriks, G Thinakaran, C L Harris, et al.
The Journal of General Virology|July 1, 1976
Persistent herpes simplex virus infections established in two Burkitt lymphoma derived cell linesW G Robey, B J Graham, C L Harris, et al.
Immunology|October 31, 2001
Tissue distribution of products of the mouse decay-accelerating factor (DAF) genes. Exploitation of a Daf1 knock-out mouse and site-specific monoclonal antibodiesF Lin, Y Fukuoka, A Spicer, et al.
Neurobiology of Disease|July 17, 1998
Stable association of presenilin derivatives and absence of presenilin interactions with APPG Thinakaran, J B Regard, C M Bouton, et al.
Immunobiology|August 20, 2011
Variation in complement component C1 inhibitor in age-related macular degenerationJ Gibson, S Hakobyan, A J Cree, et al.
The Journal of Biological Chemistry|November 14, 1997
Evidence that levels of presenilins (PS1 and PS2) are coordinately regulated by competition for limiting cellular factorsG Thinakaran, C L Harris, T Ratovitski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2000
Pigs express multiple forms of decay-accelerating factor (CD55), all of which contain only three short consensus repeatsJ M Pérez de la Lastra, C L Harris, S J Hinchliffe, et al.
Journal of the American Dietetic Association|April 29, 1998
A randomized controlled trial evaluating nutrition counseling with or without oral supplementation in malnourished HIV-infected patientsL Rabeneck, A Palmer, J B Knowles, et al.
Osteoarthritis and Cartilage|November 17, 2009
The human pharmacokinetics of oral ingestion of glucosamine and chondroitin sulfate taken separately or in combinationC G Jackson, A H Plaas, J D Sandy, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Journal of Immunology (Baltimore, Md. : 1950)|April 8, 1998
A bispecific monoclonal antibody directed against both the membrane-bound complement regulator CD55 and the renal tumor-associated antigen G250 enhances C3 deposition and tumor cell lysis by complementV T Blok, M R Daha, O Tijsma, et al.
Neuroreport|May 6, 1997
Processing of presenilin 1 in brains of patients with Alzheimer's disease and controlsL Hendriks, G Thinakaran, C L Harris, et al.
The Journal of General Virology|July 1, 1976
Persistent herpes simplex virus infections established in two Burkitt lymphoma derived cell linesW G Robey, B J Graham, C L Harris, et al.
Immunology|October 31, 2001
Tissue distribution of products of the mouse decay-accelerating factor (DAF) genes. Exploitation of a Daf1 knock-out mouse and site-specific monoclonal antibodiesF Lin, Y Fukuoka, A Spicer, et al.
Neurobiology of Disease|July 17, 1998
Stable association of presenilin derivatives and absence of presenilin interactions with APPG Thinakaran, J B Regard, C M Bouton, et al.
Immunobiology|August 20, 2011
Variation in complement component C1 inhibitor in age-related macular degenerationJ Gibson, S Hakobyan, A J Cree, et al.
The Journal of Biological Chemistry|November 14, 1997
Evidence that levels of presenilins (PS1 and PS2) are coordinately regulated by competition for limiting cellular factorsG Thinakaran, C L Harris, T Ratovitski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2000
Pigs express multiple forms of decay-accelerating factor (CD55), all of which contain only three short consensus repeatsJ M Pérez de la Lastra, C L Harris, S J Hinchliffe, et al.
Journal of the American Dietetic Association|April 29, 1998
A randomized controlled trial evaluating nutrition counseling with or without oral supplementation in malnourished HIV-infected patientsL Rabeneck, A Palmer, J B Knowles, et al.
Osteoarthritis and Cartilage|November 17, 2009
The human pharmacokinetics of oral ingestion of glucosamine and chondroitin sulfate taken separately or in combinationC G Jackson, A H Plaas, J D Sandy, et al.
Pageof 10